(Q28272573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

Rupatadine in allergic rhinitis and chronic urticaria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1 reference

Giorgio Walter Canonica

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

8

M Maurer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

6

M L Kowalski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

5

A Gimenez-Arnau

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

2

J Bousquet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

J Mullol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Bachert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

E Martí-Guadaño

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

C Picado

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

G Scadding

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

P Van Cauwenberge

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

63 Suppl 87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

5-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18339040%20AND%20SRC:MED&resulttype=core&format=json

Rupatadine: pharmacological profile and its use in the treatment of allergic disorders

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2008.01640.X

Allergic rhinitis and its impact on asthma

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

EAACI/GA2LEN/EDF guideline: management of urticaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Overview of comorbid associations of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

21 January 2018

One airway, one disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

The impact of chronic urticaria on the quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Towards rationalizing the nomenclature and classification of urticaria: some guidance on guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

EAACI/GA2LEN/EDF guideline: definition, classification and diagnosis of urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Chronic idiopathic urticaria treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Chronic urticaria: aetiology, management and current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Rupatadine: a review of its use in the management of allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Allergic rhinitis: not purely a histamine-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Pathophysiology of the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Clinical advantages of dual activity in allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Dual acting antihistaminergic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: a single-dose, randomized, open-label, two-way crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X

Comparing the new antihistamines: the role of pharmacological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01640.X